[ad_1] SHANGHAI, Dec. 4, 2023 /PRNewswire/ — On 4 Dec. 2023, Abbisko Therapeutics announced that it has entered into a licensing agreement with Merck, a leading science and technology company…
[ad_1] SHANGHAI, Dec. 4, 2023 /PRNewswire/ — On 4 Dec. 2023, Abbisko Therapeutics announced that it has entered into a licensing agreement with Merck, a leading science and technology company…